Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP

NCT04929548 · clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Wuhan University